Funder: Gilead Sciences
Due Dates: June 25, 2026 (Research Scholars Program – U.S. HIV)
Funding Amounts: $180,000 per award (2 years, paid in annual installments; 4 awards expected)
Summary: Supports innovative, independent HIV research by early-career investigators in the U.S. to advance scientific understanding and address unmet needs.
Key Information: Applicants must be early-stage faculty, meet NIH ESI criteria, and not propose research on specific Gilead products.